EVOKEDX Trademark

Trademark Overview


On Thursday, May 8, 2014, a trademark application was filed for EVOKEDX with the United States Patent and Trademark Office. The USPTO has given the EVOKEDX trademark a serial number of 86275737. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, August 19, 2021. This trademark is owned by Konan Medical USA, Inc.. The EVOKEDX trademark is filed in the Medical Instrument Products category with the following description:

Visual electrophysiology diagnostic apparatus for visual pathway examination and assessment for medical use
evokedx

General Information


Serial Number86275737
Word MarkEVOKEDX
Filing DateThursday, May 8, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, August 19, 2021
Registration Number4809617
Registration DateTuesday, September 8, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 18, 2014

Trademark Statements


Pseudo MarkEVOKE DX
Goods and ServicesVisual electrophysiology diagnostic apparatus for visual pathway examination and assessment for medical use

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, May 21, 2014
Primary Code010
First Use Anywhere DateThursday, July 9, 2015
First Use In Commerce DateThursday, July 9, 2015

Trademark Owner History


Party NameKonan Medical USA, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Party NameKonan Medical USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Party NameKonan Medical USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events


Event DateEvent Description
Thursday, May 22, 2014NOTICE OF PSEUDO MARK E-MAILED
Wednesday, May 21, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 24, 2014EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 24, 2014EXAMINERS AMENDMENT E-MAILED
Wednesday, September 24, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 24, 2014EXAMINER'S AMENDMENT ENTERED
Wednesday, September 24, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 9, 2014ASSIGNED TO LIE
Friday, August 22, 2014ASSIGNED TO EXAMINER
Monday, August 25, 2014NON-FINAL ACTION WRITTEN
Monday, August 25, 2014NON-FINAL ACTION E-MAILED
Monday, August 25, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 10, 2015TEAS STATEMENT OF USE RECEIVED
Wednesday, August 5, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 6, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 26, 2015ASSIGNED TO EXAMINER
Wednesday, October 15, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 29, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 18, 2014PUBLISHED FOR OPPOSITION
Tuesday, November 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 13, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 10, 2015USE AMENDMENT FILED
Tuesday, August 4, 2015STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 4, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 8, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, September 8, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 23, 2021TEAS SECTION 8 & 15 RECEIVED
Thursday, August 19, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, August 19, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, February 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 19, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, September 8, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED